Study of the Safety and Biologic Activity of XOMA 052 in Subjects With Type 2 Diabetes Mellitus

Mise à jour : Il y a 4 ans
Référence : NCT01144975

Femme et Homme

  • | Pays :
  • Mexico
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The study hypothesis is that XOMA 052 is likely to improve glycemic control in subjects with Type 2 Diabetes Mellitus. The purpose of this study is to determine whether XOMA 052 improves glycemic control in subjects on Metformin monotherapy whose diabetes is still not adequately controlled.


Critère d'inclusion

  • Type 2 diabetes mellitus

Liens